SARS-Cov-2

Numerous studies have shown that racial minority groups have been disproportionately affected by the COVID-19 pandemic. Experts at IDWeek said this has a lot do with history.

Safety monitoring found “no unexpected patterns of adverse reactions” among thousands of Americans who have received a third dose of a COVID-19 messenger RNA vaccine, researchers reported in MMWR.

“Can we not talk about COVID-19?” asked my friend, interrupting me mid-sentence as I tried to convince him to take the COVID-19 vaccine.

The Moderna vaccine was found to be more effective than the Pfizer-BioNTech vaccine at preventing symptomatic COVID-19 in U.S. health care workers, according to findings published in The New England Journal of Medicine.

In a new study, approved asthma biologics and systemic corticosteroids were not associated with an increased risk for SARS-CoV-2 infection, but use of systemic corticosteroids was linked with worse COVID-19 outcomes.

The Pfizer-BioNTech COVID-19 vaccine elicited “relatively lower” antibody levels in adults aged 50 years or older than in adults aged younger than 50 years, researchers reported in JAMA Network Open.

CDC Director Rochelle P. Walensky, MD, MPH, issued a statement late Thursday night endorsing her vaccine advisory committee’s recommendations — made earlier in the day — on which Americans should be eligible for COVID-19 booster shots.

In the wake of the COVID-19 pandemic, data indicate that there has been a surge in interest among U.S. college students in pursuing medicine as a career.

Additional doses of COVID-19 vaccine became available to people in the United States around 8 months after the first vaccine was authorized by the FDA.

Spongiotic dermatitis was the most commonly reported cutaneous reaction to COVID-19 vaccination among patients who also had biopsy results available for review, according to a registry-based study.